2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$50.68+$0.04 (+0.09%)
Price as of Jul 13, 2026 7:58 PM EDT- $5.3BMarket Cap
- -10.26%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$50.68+$0.04 (+0.09%)
Earnings Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -4.48% | ||
12-Month Momentum | -12.96% | ||
3-Month Risk Adjusted Momentum | -16.82% | ||
12-Month Risk Adjusted Momentum | -21.48% |
True Yield
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.68% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |